Board Meeting1 Jul 2026, 04:29 pm
Sarda Proteins Board Meeting on July 4, 2026, to Discuss Equity Increase
AI Summary
Sarda Proteins Ltd has announced a Board of Directors meeting scheduled for July 4, 2026. The primary agenda items include considering and approving a significant increase in the company's authorized equity share capital, from ₹13 crore to ₹100 crore. Additionally, the board will discuss alterations to the Memorandum of Association (MOA) object clause, approve a draft EGM notice, and appoint a scrutinizer for the upcoming Extra-ordinary General Meeting. This move signals potential expansion or strategic financial restructuring for the company.
Key Highlights
- Board meeting scheduled for July 4, 2026.
- Proposal to increase authorized equity capital from ₹13 Cr to ₹100 Cr.
- Agenda includes MOA alteration and EGM notice approval.
- Appointment of a scrutinizer for the EGM is also planned.
Price Impact
More from SRDAPRT